LONG-TERM SURVIVAL OF XENOGENEIC PANCREATIC-ISLET GRAFTS INDUCED BY CTLA4IG

被引:1144
|
作者
LENSCHOW, DJ
ZENG, YJ
THISTLETHWAITE, JR
MONTAG, A
BRADY, W
GIBSON, MG
LINSLEY, PS
BLUESTONE, JA
机构
[1] UNIV CHICAGO,BEN MAY INST,CHICAGO,IL 60637
[2] UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637
[3] UNIV CHICAGO,DEPT SURG,CHICAGO,IL 60637
[4] UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637
[5] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
D O I
10.1126/science.1323143
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Antigen-specific T cell activation depends on T cell receptor-ligand interaction and co-stimulatory signals generated when accessory molecules bind to their ligands, such as CD28 to the B7 (also called BB1) molecule. A soluble fusion protein of human CTLA-4 (a protein homologous to CD28) and the immunoglobulin (Ig) G1 Fc region (CTLA4Ig) binds to human and murine B7 with high avidity and blocks T cell activation in vitro. CTLA4Ig therapy blocked human pancreatic islet rejection in mice by directly affecting T cell recognition of B7+ antigen-presenting cells. In addition, CTLA4Ig induced long-term, donor-specific tolerance, which may have applications to human organic transplantation.
引用
收藏
页码:789 / 792
页数:4
相关论文
共 50 条
  • [1] IMMUNOMODULATION OF PANCREATIC-ISLET ALLOGRAFTS IN MICE WITH CTLA4IG SECRETING MUSCLE-CELLS
    CHAHINE, AA
    YU, M
    MCKERNAN, MM
    STOECKERT, C
    LAU, HT
    TRANSPLANTATION, 1995, 59 (09) : 1313 - 1318
  • [2] LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC-ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS
    ZENG, Y
    ILDSTAD, ST
    WREN, SM
    RILO, HLR
    BEREITER, DR
    CARROLL, PB
    TZAKIS, AG
    STARZL, TE
    RICORDI, C
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (03) : 985 - 985
  • [3] CTLA4Ig introduced by adenovirus vector locally to prolong the survival of xenogeneic skin grafts on rat burn wounds
    Luo, GX
    Wu, J
    Chen, XW
    He, WF
    Yi, SX
    Xie, ZJ
    Zheng, JS
    Zhu, J
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (05): : 1209 - 1215
  • [4] THE INFLUENCE OF CYCLOSPORINE ON THE MICROVASCULATURE OF XENOGENEIC PANCREATIC-ISLET GRAFTS
    MENGER, MD
    JAGER, S
    WOLF, B
    MESSMER, K
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (04) : 2217 - 2218
  • [5] CTLA4Ig gene transfer induces pancreatic islet graft prolongation
    Yang, ZD
    Chen, M
    Rostami, S
    Gelman, A
    Wolf, B
    Shaked, A
    Barker, C
    Naji, A
    DIABETES, 1998, 47 : A67 - A67
  • [6] LONG-TERM SURVIVAL OF PANCREATIC-ISLET ALLOGRAFTS IN PANCREATECTOMIZED DOGS
    ALEJANDRO, R
    CUTFIELD, R
    SHIENVOLD, FL
    LATIF, Z
    KYRIAKIDES, GK
    MILLER, J
    MINTZ, DH
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (04) : 829 - 830
  • [7] Long-term survival of encapsulated xenogeneic islets in diabetic NOD mice treated with CTLA4-Ig.
    Safley, SA
    Hagler, M
    Kapp, L
    Linsley, P
    Weber, CJ
    Kapp, JA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1109 - 1109
  • [8] Long-term therapy with the selective costimulation modulator CTLA4Ig in rheumatoid arthritis
    Alten, R
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (03): : 252 - +
  • [9] LONG-TERM ACCEPTANCE OF CARDIAC ALLOGRAFTS INDUCED BY CTLA4IG PLUS DONOR-SPECIFIC TRANSFUSION
    LIN, H
    BOLLING, S
    LINSLEY, P
    WEI, RQ
    THOMPSON, C
    TURKA, L
    CLINICAL RESEARCH, 1993, 41 (03): : A679 - A679
  • [10] CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression
    Laumonier, T
    Potiron, N
    Boeffard, F
    Chagneau, C
    Brouard, S
    Guillot, C
    Soulillou, JP
    Anegon, I
    Le Mauff, B
    HUMAN GENE THERAPY, 2003, 14 (06) : 561 - 575